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a b s t r a c t
Shifts in intracellular Reactive Oxygen Species (ROS) have been shown to contribute to carcinogenesis and to
tumor progression. In addition to DNA and cell damage by surges in ROS, sub-lethal increases in ROS are
implicated in regulating cellular signaling that enhances pro-metastatic behavior. We previously showed that
subtle increases in endogenous H2O2 regulate migratory and invasive behavior of metastatic bladder cancer
cells through phosphatase inhibition and consequential phosphorylation of p130cas, an adapter of the FAK
signaling pathway. We further showed that enhanced redox status contributed to enhanced localization of
p130cas to the membrane of metastatic cells. Here we show that this signaling complex can similarly be
induced in a redox-engineered cell culture model that enables regulation of intracellular steady state H2O2
level by enforced expression of superoxide dismutase 2 (Sod2) and catalase. Expression of Sod2 leads to
enhanced p130cas phosphorylation in HT-1080 ﬁbrosarcoma and UM-UC-6 bladder cancer cells. These
changes are mediated by H2O2, as co-expression of Catalase abrogates p130cas phosphorylation and its
interaction with the adapter protein Crk. Importantly, we establish that the redox environment inﬂuence the
localization of the tumor suppressor and phosphatase PTEN, in both redox-engineered and metastatic
bladder cancer cells that display endogenous increases in H2O2. Importantly, PTEN oxidation leads to its
dissociation from the plasma membrane. This indicates that oxidation of PTEN not only inﬂuences its activity,
but also regulates its cellular localization, effectively removing it from its primary site of lipid phosphatase
activity. These data introduce hitherto unappreciated paradigms whereby ROS can reciprocally regulate the
cellular localization of pro- and anti-migratory signaling molecules, p130cas and PTEN, respectively. These
data further conﬁrm that altering antioxidant status and the intracellular ROS environment can have
profound effects on pro-metastatic signaling pathways.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Redox signaling is implicated in regulating a diverse range of
cellular functions. In diseases, such as cancer, sub-lethal increases in
intracellular ROS have been associated with aberrant signaling that
exasperates pathophysiological phenotypes. It has been shown that
metastatic tumor cells display elevated in intracellular ROS and
alterations in their antioxidant status [1–3]. For example, many
aggressive cancers display increased mitochondrial manganese
superoxide dismutase (Sod2) levels and loss of catalase (CAT) expres-
sion that are associated with stage and grade of disease progression
and poor patient outcome. This shift in antioxidant enzyme levels may
be an intrinsic adaptation of metastatic cancer cells to cope with
changes in intracellular ROS [3]. A number of studies indicate that
metastatic tumor cells have the capability to utilize these increases in
ROS to regulate transcription and cellular signaling that contribute to
metastatic disease progression [4–7].
We have developed number of cell culture models, which
either display endogenous increases in intracellular ROS as a result
of acquisition of the metastatic phenotype or through manipula-
tion of antioxidant enzyme expression. We have observed that
increased intracellular ROS levels can drive migration, invasion
and metastasis in vitro and in vivo, and have begun to elucidate the
redox-sensitive molecular triggers that accompany the metastatic
phenotype [7–9]. Using a bladder cancer cell culture model of
metastatic disease progression we have shown that a highly meta-
static cell line derivative (253J-BV) relies on redox-mediated signal-
ing to drive its migratory and invasive phenotype compared to a
related non-metastatic parental cell line [7,10]. Subtle increases in
the ROS milieu have been shown to have profound effects on pro-
metastatic signaling of the Focal Adhesion Kinase (FAK) pathway by
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enhancing signaling through the adapter protein p130cas (Crk-
associated substrate) which links FAK to Rac-1 activation and
cytoskeletal rearrangement during the process of migration and focal
adhesion formation [7]. Redox regulation of signaling occurs primar-
ily through reversible oxidation of proteins, which is particularly
prevalent in the case of phosphatases, where active site cysteine
residues are susceptible to oxidation due to their relatively low pKa
[11]. Increases in endogenous steady state H2O2 enhance oxidation of
the phosphatase pool, p130cas function and migratory activity of the
metastatic 253J-BV bladder cancer cells through the oxidative
inhibition the p130cas inhibitory phosphatase, PTP-N12 [7]. In
addition, ROS play a pivotal role in oxidative inactivation of the dual
protein and lipid phosphatase PTEN (phosphatase and tensin homo-
log), leading to redistribution of the phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) pools at the plasmalamellar membrane, enhan-
cing Akt signaling and tumor cell migration [12–14].
In the present study we show that redox-regulation of p130cas
signaling is not limited to metastatic bladder cancer cells, but can
similarly be induced by altering steady state H2O2 levels following
manipulation of Sod2 and CAT expression. We previously used this
model to show that Sod2-mediated changes in steady state H2O2 lead
to an enhanced metastatic and angiogenic phenotype through PTEN
oxidation and increased VEGF expression. We have also established
that the Sod2-dependent increases in H2O2 drive high level expression
of the matrix metalloproteinase MMP-1 that often accompanies
metastatic disease progression [8,9,13,15]. By modulating steady state
H2O2 levels using well characterized redox engineered ﬁbrosarcoma
cell lines [16], we observed similar changes in redox dependent
p130cas phosphorylation and its membrane recruitment. Further,
using this and a bladder cancer progression model, we demonstrate
that intracellular redox status inﬂuences both PTEN oxidation and its
cellular distribution. Oxidationmoved PTEN away from its primary site
of action at the cell membrane to the cytosol. These data show that
increases in steady state H2O2 levels can have essentially opposing
actions on membrane recruitment of pro- and anti-migratory signal-
ing players, ultimately supporting a redox-dependent pro-metastatic
signaling complex at the leading edge of metastatic tumor cells.
Results
Sod2 expression leads to H2O2-mediated p130cas phosphorylation
We previously showed that increases in both endogenous and
exogenous-applied H2O2 can stimulate p130cas phosphorylation in
253 bladder cancer cells [7]. Analysis of redox engineered HT-1080
cells [16] revealed that Sod2 overexpression similarly enhanced
p130cas phosphorylation, which was reversed by CAT co-expression
(Fig. 1A). To conﬁrm this ﬁnding, stable expression of Sod2 in another
bladder cancer cell line UM-UC-6, enhanced phosphorylation of
p130cas and FAK (Fig. 1B). Treatment of UM-UC-6 cells with exogen-
ous CAT was also able to reverse these effects, suggesting that
increases in H2O2 in response to Sod2 expression play a signiﬁcant
role in regulating phosphorylation of p130cas. In addition, Sod2
expression markedly enhanced Crk association with p130cas, which
is dependent on p130cas phosphorylation and necessary for p130cas
down-stream signaling. This association was again abrogated by CAT
co-expression (Fig. 1C). These data show that modulating antioxidant
enzyme levels similar to that observed in metastatic cells, can activate
redox-dependent signaling networks that engage migratory activity.
Loss of p130cas prevents cell migration
We previously showed that Sod2 expression enhances migration
and invasion of HT-1080 tumor cells [9]. To assess if p130cas is a
Fig. 1. Sod2-mediated shifts in redox status regulate p130cas phosphorylation. (A) p130cas phosphorylation proﬁle of redox engineered HT-1080 cells. Cells were stably
transfected with vector (CMV), Sod2 or Sod2 and CAT (Sod2/CAT) and cell lysates immunoprecipitated (IP) for phospho-tyrosine (PY-20), followed by immunoblotting (IB) for
p130cas. (B) Increased Sod2 expression enhances p30cas phosphorylation in UM-UC-6 bladder cancer cells, which is reversed by CAT treatment. UM-UC-6 cells stably
transfected with vector only (eGFP) or Sod2-eGFP. Cells were treated with recombinant CAT (500 U/ml) to assess H2O2 dependence of p130cas phosphorylation. (C) Sod2-
expressing redox-engineered cells display enhanced Crk-p130cas interaction. Cells were lysed using RIPA buffer, followed by IP with antibody against Crk and
immunoblotting with indicated antibodies. CAT co-expression abrogates association of Crk with p130cas (Sod2/CAT).
Fig. 2. p130cas knock-down signiﬁcantly abrogates migration of HT-1080 redox
engineered cells (stable-transfected with empty vector CMV, Sod2 or Sod2/CAT) in
a wound healing assay. Cells were mock transfected (-) or with siRNA construct
against p130cas or scramble control and allowed to reach a conﬂuent monolayer.
Migration of cells in serum-free media into the scratch wound was monitored for
23 h. Percentage of the distance migrated by the leading edge was quantiﬁed (n¼7;
mean7SEM, t-test, nnpo0.01, nnnpo0.001, compared to scramble control).
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necessary component in regulating migration, p130cas expression
was inhibited by siRNA. Migration of control (CMV vector) and
Sod2-expressing cells was signiﬁcantly abrogated following a
decrease in p130cas expression (Fig. 2). Interestingly, the cells co-
expressing CAT displayed little migratory activity and were unaf-
fected by loss of p130cas, indicating that efﬁcient H2O2 removal
supersedes p130cas silencing and its ability to restrict migration.
Intracellular redox status regulates cellular distribution of p130cas
to the membrane
Phosphorylation of p130cas by FAK and Src kinase is associatedwith
p130cas membrane recruitment to the leading edge of migrating cells
[17,18]. The presence of p130cas in membrane fractions was enhanced
in cells stably expressing Sod2 and decreased upon co-expression with
CAT (Fig. 3A). Levels of p130cas in membrane fractions were further
enhancedupon treatmentof cellswith exogenousH2O2. Thedifferential
pattern of p130casmembrane localizationwas conﬁrmed using immu-
noﬂuorescence analysis (Fig. 3B). In Sod2 stable expressing cells,
p130cas staining was observed more strongly in clear focal contact
patterns compared to control (CMV vector) cells, indicative of mem-
brane protrusions of migrating cells. Staining for phospho-p130caswas
reduced and p130cas redistributed to the cytoplasm, following CAT co-
expression (Sod2/CAT). This suggests that changes in intracellular H2O2,
as a consequence of differential antioxidant expression, plays a role in
the redistribution of p130cas to membrane protrusions of cells.
Increases in intracellular redox status enhance oxidation and inhibit
membrane localization of the phosphatase PTEN
PTEN is a known tumor suppressor, which exerts its anti-migratory
effects via both its lipid and protein phosphatase activities [19–21].
Fig. 3. Membrane localization of p130cas in redox engineered cells. (A) Membrane/cytoskeletal fractionation of cell lysates reveals enhanced p130cas localization to
membrane fractions of Sod2 expressing cells, which is further enhanced by treatment of cells for 10 min with 500 μM H2O2, and abrogated by CAT expression.
(B) Immunoﬂuorescence staining reveals enhanced membrane distribution of phospho p130cas in redox engineered Sod2 expressing HT-1080 cells. Cells were ﬁxed and
stained for phospho-p130cas Y165 (Alexa Fluor 488, green), Nucleus (Dapi, blue) and F-actin (Phalloidin-Texas Red; Scale bar¼10 mm). (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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PTEN has been shown to negatively regulate the FAK pathway and
enhance dephosphorylation of FAK and p130cas [22], and its activity
can be regulated by oxidation [12–14]. We have previously established
that Sod2 expression enhances PTEN oxidation using non-reducing
SDS-PAGE to distinguish between its oxidized and reduced forms [13].
In the present study, we were able to visualize this difference by
further stimulating the cells with exogenous H2O2 (Fig. 4A, lower left
panels, cytosolic fraction). Interestingly, when analyzing PTEN distri-
bution following H2O2 treatment between membrane and cytosolic
compartments, the fraction of oxidized PTEN was decreased in the
membrane compartment compared to the oxidized fraction of PTEN in
the cytosolic compartment of Sod2 expressing cells (Fig. 4A and B, A
left panels). This suggests that oxidation not only leads to inactivation
of PTEN, but also determines its cellular localization. As expected, cells
co-expressing CAT displayed little overall PTEN oxidation and the
presence of CAT abrogated the effects of exogenous H2O2 treatment.
When analyzing PTEN localization on reducing SDS-PAGE it was
apparent that the total pool of membrane associated PTEN was
decreased in cells following H2O2 treatment (Fig. 4A, upper right
panel). To conﬁrm these ﬁndings we assessed the same patterns in our
metastatic bladder cancer model [10]. Metastatic 253J-BV cells, which
display an endogenous increase in intracellular H2O2, showed
enhanced oxidation of PTEN compared to their non-metastatic par-
ental 253J cells (Fig. 4C, lower left panel, cytosolic fraction). This was
further enhanced following H2O2 treatment. The ratio of oxidized to
reduced PTEN was higher in the cytosol than in the membrane
fraction (Fig. 4C and D). Total PTEN levels at the membrane without
H2O2 treatment were signiﬁcantly decreased in the 253J-BV cells
compared to those found at the membrane of the non-metastatic
parental cells (Fig. 4C, right panel). In both cell lines total PTEN was
further sequestered away from the membrane following H2O2 treat-
ment (Fig. 4C and E, C right panels). PTEN is dependent on membrane
association for its lipid phosphatase activity and this redox-dependent
membrane dissociation represents a novel regulatory mechanism of
PTEN. Further, these data have identiﬁed a new redox-signaling
paradigm through membrane recruitment of distinct cellular signaling
complexes. As such we have shown that endogenous or Sod2-
mediated increases in H2O2 are able to drive the membrane recruit-
ment of pro-migratory signaling players, such as p130cas, yet have the
opposing effect on anti-migratory regulators, like PTEN.
Discussion
The role of ROS as novel signaling players during the process of
metastasis is becoming increasingly apparent. As novel redox-
regulated pathways are being elucidated the importance of spatio-
temporal aspects of their regulation will be realized. As such, we
show that subtle ROS changes can have profound and opposing
effects on the membrane localization of pro- and anti-migratory
signaling players and that changes in antioxidant expression may
contribute to altering the activity of these signaling networks. In
the present study, we conﬁrm our previous ﬁndings that p130cas,
an adapter protein linking FAK and Src kinase to the activation of
Rac-1, is an important mediator of redox-dependent pro-migratory
signaling. We show that manipulating steady-state H2O2 levels
by Sod2 and CAT expression can alter p130cas phosphorylation
and membrane recruitment. Interestingly, as we had previously
Fig. 4. Oxidation leads to redistribution of PTEN from the membrane to the cytosol. (A) Membrane/cytoskeletal fractionation was carried out as detailed in the Methods
section. PTEN oxidation was analyzed by differential migration of oxidized (ox.) and reduced (red.) forms on non-reducing SDS-PAGE, followed by immunoblotting. The
oxidized fraction of PTEN is less abundant in the membrane compartment (upper left panel) compared to the cytosolic compartment (lower left panel) following H2O2
(500 μM, 10 min) treatment of redox engineered HT-1080 cells. Total PTEN levels in the membrane fraction, assessed under reducing SDS-PAGE conditions, decrease
following H2O2 treatment (upper right panel). (B) Percentage quantiﬁcation of oxidized and reduced PTEN from immunoblots of membrane and cytosolic cell fractions
following H2O2 treatment (n¼3; mean7SEM). (C) A similar pattern of PTEN localization upon oxidation is observed in metastatic 253J-BV bladder cancer cells, which
display endogenous increases in steady-state H2O2 compared to their non-metastatic parental counterparts 253J cells. Basal oxidation of PTEN is higher in the cytosolic
fraction of metastatic 253J-BV bladder cancer cells (lower left panel). The oxidized fraction of PTEN is less abundant in the membrane compartment (upper left panel)
compared to the cytosolic compartment following H2O2 treatment. Total PTEN levels, are less abundant in the membrane fraction of 253J-BV cells and further decrease
following H2O2 treatment (upper right panel). (D) Quantiﬁcation of oxidized and reduced PTEN fractions following H2O2 treatment of bladder cancer cell lines (n¼3;
mean7SEM). (E) Quantiﬁcation of total PTEN (as assessed by reducing SDS-PAGE) in the membrane fraction of 253J and 253J-BV cells following treatment with 500 μMH2O2
(n¼3; mean7SEM, one-way ANOVA, npo0.05, nnpo0.01, compared to 253J untreated sample).
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observed in 253J-BV cells, Sod2 expressing HT-1080 cells also
displayed slightly enhanced total levels of p130cas (Figs. 2 and 3).
This suggests that the redox mediated increase in p130cas phosphor-
ylation enhances p130cas protein stability [7]. Dephosphorylation
has previously been shown to enhance p130cas degradation [23] and
regulation of p130cas phosphorylation by phosphatases appears to
be an important regulatory mechanism of its function [18]. Given
that many cancers display enhanced Sod2 expression with increasing
stage and grade, enhanced signaling through p130cas may be a
hallmark of these cancers, thereby increasing their metastatic
phenotype. We previously showed that the redox-mediated
increases in p130cas signaling are likely mediated through oxidation
and inactivation of phosphatases, rather than at the level of its
kinases Src and FAK [7,18,24].
The role of PTEN as a potent tumor suppressor is highlighted by the
fact that many cancer types are characterized by a loss of PTEN
expression. This dual lipid/protein phosphatase has been functionally
related to the regulation of a plethora of signaling cascades, including
those regulating migration. PTEN0s lipid phosphatase activity regulates
the levels of PIP3 at the membrane and therefore inﬂuences PI3kinase/
Akt signaling. A loss of PTEN results in enhanced PIP3 accumulation at
the leading edge and this is associated with actin cytoskeletal re-
arrangement [20,21]. PTEN0s lipid phosphatase activity has also been
implicated in regulating the directionality of movement [21]. At the
protein level, phosphorylation and oxidation are known mechanisms
that regulate PTEN activity [14,25]. We have previously reported that
alterations in the steady state levels of H2O2, through over-expression
of Sod2, can result in increased oxidation and inactivation of PTEN
[13]. This was reversed by effective removal of H2O2 following CAT
expression. Concomitant with Sod2-dependent PTEN oxidation we
saw accumulation of PIP3 at the plasma membrane [13]. PTEN0s
protein phosphatase activity has also been implicated in negatively
regulating migration. A loss of PTEN promotes migration via activation
of Rac-1 and CDC 42 [26]. It is also thought that PTEN0s protein phos-
phatase activity is responsible for regulating epithelial to mesenchy-
mal transition [19]. PTEN over-expression can decrease FAK and
p130cas phosphorylation, implicating it as an important phosphatase
in regulating p130cas signaling, in addition to PTP-N12 [22,27].
The distribution of PTEN is known to be spatially regulated and
believed to be important for the differential distribution of PIP3 and
PIP2 at the leading and lagging edges, respectively [28]. Interestingly,
like its anti-migratory activity, it has recently been shown that PTEN
membrane recruitment is regulated by de-phosphorylation of its
C-terminus, allowing for an ”open” conﬁguration and PIP3 binding
[25]. Our data provide new evidence that oxidation of PTEN, like
phosphorylation, restricts its membrane recruitment (Fig. 4). Whether
oxidation leads to a conformational change that inhibits binding of
PTEN to the membrane via PIP3 remains to be investigated. One could
speculate that an alternative scenario may involve the inhibition of
PTEN phosphatase activity via oxidation of its active site cysteines, and
a subsequent loss of PTEN to auto-dephosphorylate its C terminus.
This would result in enhanced phosphorylation and a “closed” C2
domain conﬁrmation, leading to loss of membrane association. The
concept that subtle picomolar increases in intracellular H2O2 can
essentially have opposing effects on membrane localization of pro-
and anti-migratory signaling players, such as p130cas and PTEN,
respectively, is extremely novel and adds another layer to the ever
expanding role of ROS as regulators of cellular signaling.
Methods
Cell culture, treatments and transfection
Redox engineered human HT-1080 ﬁbrosarcoma cells were
created by stable expression of Sod2, Sod2 and cytosol-targeted
CAT (Sod2/CAT) or empty vector (CMV) and cultured in MEM with
10% FBS, 1 mg/ml G418 and Pen/Strep [16]. Human urothelial
carcinoma cells UM-UC-6 were stably transfected with eGFP or
Sod2-eGFP constructs constructs and cultured in DMEM media
containing 10% FBS, 1% MEM Vitamins, 1% penicillin/streptomycin
solution, 1% sodium pyruvate, 1% amino acids, 1% L-glutamine, Pen/
Strep and 0.5 μg/ml puromycin (Ye H. and Melendez J.A. et al.,
manuscript in revision). The highly metastatic bladder cancer cell
line 253J-BV was derived from a poorly metastatic parental human
bladder adenocarcinoma cell line, 253J, following ﬁve successive
bladder xenografts [29]. 253J and 253J-BV cells were cultured in
DMEM, with 4.5 g/L L-glucose, sodium piruvate and 10% FBS in a
37 1C humidiﬁed, 5% CO2 incubator [10].
For H2O2 (Sigma) treatments, cells were exposed to H2O2 at
indicated doses and times in serum free DMEM. For catalase (CAT)
treatments, cells were pretreated in 10% serum DMEM with 500 U/
ml recombinant bovine CAT (Sigma) or 2 mM N-acetyl cysteine
(NAC; Sigma) for 24 h. This was followed by treating the cells with
the same concentrations in serum free media for an additional 18 h.
Antibodies, immunoblotting and immunoprecipitation
Crk and p130cas antibodies were purchased from BD Transduc-
tion Labs, Phospho-p130cas-Y165 and PTEN antibodies from Cell
signaling, CAT and PY20 phospho tyrosine antibodies from Abcam,
and GAPDH antibody from Ambion. Cleared cell lysates for co-IP and
phospho-protein analysis were obtained using RIPA buffer lysis
(150 mM NaCl, 50 mM Tris (pH 7.5), 1% NP-40, 0.5% deoxycholate,
EDTA-free protease inhibitor cocktail, 1 mM sodium orthovanadate),
followed by centrifugation (14,000 rpm, 15 min, 4 1C). Protein con-
centration was obtained using the BCA protein assay (Pierce/Thermo
Scientiﬁc) and equal protein loaded on 4–12% NuPAGE (Invitrogen).
For immunoprecipitation 1 mg of protein was incubated with 1 μg
anti-Crk antibody (mouse IgG control) overnight at 4 1C, followed by
incubation with protein G sepharose (30 μl). Proteins were eluded in
2x reducing SDS-PAGE sample buffer and electrophoresed, followed
by transfer to nitrocellulose membranes (Invitrogen iBlot transfer
system). Primary antibody incubation was carried out in 5% BSA TBS-
0.1%Tween (1:1000) overnight at 4 1C, followed by washes in TBS-
0.1%Tween. HRP-conjugated secondary antibody (Amersham/GE
Healthcare) incubations were carried out at 1:10,000 dilutions in
5% Milk TBS-0.1%Tween, followed by chemiluminescence detection
with ECL reagents (Pierce/Thermo Scientiﬁc). All blots are represen-
tatives of three or more replicate experiments.
Wound healing assays
siRNA constructs were transfected into cells using RNAi Max
Lipofectamine reagent (Invitrogen). Brieﬂy, 200,000 cells were trans-
fected with either 100 pmol p130cas siRNA (Santa Cruz Biotechnol-
ogy) or equal molar concentration of non-targeting siRNA (control #1,
Thermo Scientiﬁc Dharmacon). Cells were grown to monolayer
conﬂuence and wounds created using a P200 sterile pipette tip. Cells
were allowed to move in 0% serum media at 37 1C and monitored for
movement by taking brightﬁeld images at time 0 and indicated time
intervals. Images were obtained using a Zeiss Axio Observer.Z1 with
an EC Plan-Neoﬂuar 5x/0.15 M27 objective and AxiocamMR3. Dis-
tances were measured using Axiovision (Zeiss) software and subse-
quent image processing (ie marking of original wound edge)
undertaken using Adobe Photoshop. Migration of cells was quantiﬁed
as % distance migrated by leading edge.
Membrane/cytoskeletal fractionation
The membrane/cytoskeletal fractions were obtained using a
protocol adapted from [30], as described in [7]. Brieﬂy, cells were
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washed in PBS, followed by lysis in ice-cold CSK buffer (0.5% Triton
X-100, 10 mM TrisHCl (pH 6.8), 50 mM NaCl, 300 mM sucrose,
3 mM MgCl2, 1 mM sodium orthovanadate and protease inhibi-
tors). Following centrifugation (13,600 g, 30 min), the Triton X
soluble cytosolic fraction was removed and analyzed for protein
content. The Triton X insoluble pellet (membrane/cytoskeletal
fraction) was washed with CSK buffer, and boiled to resuspend
in SDS buffer (1% SDS, 10 mM TrisHCl (pH 7.5), 2 mM EDTA, 1 mM
sodium orthovanadate and protease inhibitors). Cell debris was
collected by centrifugation at 13,600 g for 30 min at 4 1C and the
supernatant Triton X insoluble fraction (membrane/cytoskeletal
fraction) saved. Equivalent amounts of Triton X insoluble fraction
in reference to protein concentration of the soluble fraction were
loaded on 10% SDS-PAGE, followed by immunoblotting. For PTEN
experiments, N-ethylmaleimide (NEM, 40 mM) was added to
buffers to inhibit oxidation of the protein following lysis. Samples
were run in non-reducing sample buffer to separate reduced and
oxidized forms of PTEN on SDS-PAGE.
Immunoﬂuorescence staining
Cells were seeded on glass coverslips, ﬁxed with 4% parafor-
maldehyde/PBS, permeabilized with 0.1% Triton X 100/PBS and
blocked in 3% FBS/PBS. Cells were incubated with primary anti-
body Phospho p130cas Y165 at a dilution of 1:100 in 3%FBS/PBS,
followed by incubation with anti rabbit Alexa-Fluor 488 conju-
gated secondary antibody (Invitrogen, 1:1000 in 3% FBS/PBS).
F-actin was stained with Phaloidin TexasRed (Invitrogen, 1:50
dilution) and nuclear DNA with Dapi. Cells were mounted using
Prolong Gold Antifade reagent (Invitrogen) and visualized on a
Zeiss Axio Observer Z1 Fluorescence Microscope, using a
631.25 NA oil immersion objective and AxioCam MR3 with
Apotome attachment. Image analysis was performed using Zeiss
Axiovision software.
Statistical analysis
Data are presented as mean 7 standard error of the mean
(SEM). T-tests and one-way ANOVA with Tukey0s Multiple Com-
parison Post-tests were performed using GraphPad Prism v6,
GraphPad Software, San Diego California USA.
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